In primary AML samples, %annexinV and %active caspase-3 (Supplementary Figs. S7A–C and S8A–C, respectively) were not significantly different at low concentrations, with any drug combination pair tested. This evidence concerns the gene CASP3 and acute myeloid leukemia.